These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30128866)

  • 21. CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC).
    Tian Y; Wu J; Chagas C; Du Y; Lyu H; He Y; Qi S; Peng Y; Hu J
    BMC Cancer; 2018 Nov; 18(1):1187. PubMed ID: 30497429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue.
    Rao UN; Gollin SM; Beaves S; Cieply K; Nalesnik M; Michalopoulos GK
    Mol Diagn; 2001 Mar; 6(1):27-37. PubMed ID: 11257209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.
    Luo Q; Wang CQ; Yang LY; Gao XM; Sun HT; Zhang Y; Zhang KL; Zhu Y; Zheng Y; Sheng YY; Lu L; Jia HL; Yu WQ; Liu J; Dong QZ; Qin LX
    Cancer Lett; 2018 Mar; 417():21-34. PubMed ID: 29248714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma.
    Kusano N; Okita K; Shirahashi H; Harada T; Shiraishi K; Oga A; Kawauchi S; Furuya T; Sasaki K
    Cancer; 2002 Feb; 94(3):746-51. PubMed ID: 11857308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.
    Kusano N; Shiraishi K; Kubo K; Oga A; Okita K; Sasaki K
    Hepatology; 1999 Jun; 29(6):1858-62. PubMed ID: 10347130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis.
    Zhou S; Shen J; Lin S; Liu X; Xu M; Shi L; Wang X; Cai X
    Tumour Biol; 2016 Oct; 37(10):13607-13616. PubMed ID: 27468723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.
    Hertz S; Rothämel T; Skawran B; Giere C; Steinemann D; Flemming P; Becker T; Flik J; Wiese B; Soudah B; Kreipe H; Schlegelberger B; Wilkens L
    Pathobiology; 2008; 75(5):312-22. PubMed ID: 18931534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
    Schlaeger C; Longerich T; Schiller C; Bewerunge P; Mehrabi A; Toedt G; Kleeff J; Ehemann V; Eils R; Lichter P; Schirmacher P; Radlwimmer B
    Hepatology; 2008 Feb; 47(2):511-20. PubMed ID: 18161050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copy number of 8q24.3 drives HSF1 expression and patient outcome in cancer: an individual patient data meta-analysis.
    Brusselaers N; Ekwall K; Durand-Dubief M
    Hum Genomics; 2019 Nov; 13(1):54. PubMed ID: 31699156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
    Tanaka Y; Kanai F; Tada M; Tateishi R; Sanada M; Nannya Y; Ohta M; Asaoka Y; Seto M; Shiina S; Yoshida H; Kawabe T; Yokosuka O; Ogawa S; Omata M
    J Hepatol; 2008 Nov; 49(5):746-57. PubMed ID: 18752864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
    Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
    Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic function and prognostic significance of Abelson interactor 1 in hepatocellular carcinoma.
    Wang JL; Yan TT; Long C; Cai WW
    Int J Oncol; 2017 May; 50(5):1889-1898. PubMed ID: 28339046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of ATAD2 in different liver lesions and its clinical significance].
    Liu F; Zhou X; Ji HH; Li H; Xiang FG
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):339-343. PubMed ID: 28763839
    [No Abstract]   [Full Text] [Related]  

  • 38. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372.
    Wang Y; Hu Y; Wu G; Yang Y; Tang Y; Zhang W; Wang K; Liu Y; Wang X; Li T
    Oncotarget; 2017 May; 8(21):34429-34441. PubMed ID: 28415780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
    Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
    Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.